peak proteins ltd. Company Information
Company Number
09265797
Next Accounts
Dec 2024
Industry
Dormant Company
Research and experimental development on biotechnology
Shareholders
sygnature discovery limited
evergreen holdco 3 limited
Group Structure
View All
Contact
Registered Address
the discovery building biocity, pennyfoot street, nottingham, nottinghamshire, NG1 1GR
Website
www.peakproteins.compeak proteins ltd. Estimated Valuation
Pomanda estimates the enterprise value of PEAK PROTEINS LTD. at £0 based on a Turnover of £3.9m and 0x industry multiple (adjusted for size and gross margin).
peak proteins ltd. Estimated Valuation
Pomanda estimates the enterprise value of PEAK PROTEINS LTD. at £0 based on an EBITDA of £1.4m and a 0x industry multiple (adjusted for size and gross margin).
peak proteins ltd. Estimated Valuation
Pomanda estimates the enterprise value of PEAK PROTEINS LTD. at £0 based on Net Assets of £4.3m and 0x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Peak Proteins Ltd. Overview
Peak Proteins Ltd. is a live company located in nottingham, NG1 1GR with a Companies House number of 09265797. It operates in the dormant company sector, SIC Code 99999. Founded in October 2014, it's largest shareholder is sygnature discovery limited with a 51.9% stake. Peak Proteins Ltd. is a established, small sized company, Pomanda has estimated its turnover at £3.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Peak Proteins Ltd. Health Check
Pomanda's financial health check has awarded Peak Proteins Ltd. a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 1 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
1 Weak
Size
annual sales of £3.9m, make it in line with the average company (£4m)
£3.9m - Peak Proteins Ltd.
£4m - Industry AVG
Growth
3 year (CAGR) sales growth of 41%, show it is growing at a faster rate (8.7%)
- Peak Proteins Ltd.
8.7% - Industry AVG
Production
with a gross margin of 85.1%, this company has a lower cost of product (44.2%)
85.1% - Peak Proteins Ltd.
44.2% - Industry AVG
Profitability
an operating margin of 29.5% make it more profitable than the average company (2.2%)
29.5% - Peak Proteins Ltd.
2.2% - Industry AVG
Employees
with 37 employees, this is similar to the industry average (46)
37 - Peak Proteins Ltd.
46 - Industry AVG
Pay Structure
on an average salary of £40.3k, the company has a lower pay structure (£55.5k)
£40.3k - Peak Proteins Ltd.
£55.5k - Industry AVG
Efficiency
resulting in sales per employee of £105.7k, this is less efficient (£146.2k)
£105.7k - Peak Proteins Ltd.
£146.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Peak Proteins Ltd.
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Peak Proteins Ltd.
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Peak Proteins Ltd.
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Peak Proteins Ltd.
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Peak Proteins Ltd.
- - Industry AVG
PEAK PROTEINS LTD. financials
Peak Proteins Ltd.'s latest turnover from March 2023 is £3.9 million and the company has net assets of £4.3 million. According to their latest financial statements, Peak Proteins Ltd. has 37 employees and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|
Turnover | 3,912,168 | 3,580,292 | ||||||
Other Income Or Grants | 0 | 0 | ||||||
Cost Of Sales | 584,864 | 550,550 | ||||||
Gross Profit | 3,327,304 | 3,029,742 | ||||||
Admin Expenses | 2,173,684 | 1,914,275 | ||||||
Operating Profit | 1,153,620 | 1,115,467 | ||||||
Interest Payable | 91 | 0 | ||||||
Interest Receivable | 0 | 0 | ||||||
Pre-Tax Profit | 1,153,529 | 1,115,467 | ||||||
Tax | 0 | 693 | ||||||
Profit After Tax | 1,153,529 | 1,116,160 | ||||||
Dividends Paid | 0 | 0 | ||||||
Retained Profit | 1,153,529 | 1,116,160 | ||||||
Employee Costs | 1,491,528 | 1,229,895 | ||||||
Number Of Employees | 37 | 27 | 22 | 18 | 12 | 9 | 6 | 4 |
EBITDA* | 1,387,453 | 1,273,215 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 1,785,477 | 733,001 | 374,513 | 192,593 | 160,712 | 63,210 | 33,315 |
Intangible Assets | 0 | 0 | 0 | 0 | 94 | 219 | 344 | 469 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 5,642 | 5,642 | 5,642 | 5,642 | 5,642 | 5,321 |
Total Fixed Assets | 0 | 1,785,477 | 738,643 | 380,155 | 198,329 | 166,573 | 69,196 | 39,105 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 506,762 | 388,183 | 181,094 | 166,734 | 55,740 | 33,674 | 9,459 |
Group Debtors | 1,912,481 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 142,143 | 124,654 | 87,367 | 55,835 | 30,256 | 14,244 | 7,129 |
Cash | 2,357,839 | 957,730 | 886,586 | 508,036 | 341,321 | 213,807 | 277,323 | 110,070 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 4,270,320 | 1,606,635 | 1,399,423 | 776,497 | 563,890 | 299,803 | 325,241 | 126,658 |
total assets | 4,270,320 | 3,392,112 | 2,138,066 | 1,156,652 | 762,219 | 466,376 | 394,437 | 165,763 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 185,984 | 150,324 | 55,613 | 45,799 | 17,473 | 14,075 | 14,220 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 199,652 | 77,425 | 50,696 | 48,758 | 36,568 | 39,793 | 2,663 |
total current liabilities | 0 | 385,636 | 227,749 | 106,309 | 94,557 | 54,041 | 53,868 | 16,883 |
loans | 0 | 0 | 20,000 | 20,000 | 40,000 | 47,861 | 47,861 | 47,828 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 20,000 | 20,000 | 40,000 | 47,861 | 47,861 | 47,828 |
total liabilities | 0 | 385,636 | 247,749 | 126,309 | 134,557 | 101,902 | 101,729 | 64,711 |
net assets | 4,270,320 | 3,006,476 | 1,890,317 | 1,030,343 | 627,662 | 364,474 | 292,708 | 101,052 |
total shareholders funds | 4,270,320 | 3,006,476 | 1,890,317 | 1,030,343 | 627,662 | 364,474 | 292,708 | 101,052 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | 1,153,620 | 1,115,467 | ||||||
Depreciation | 233,833 | 157,748 | 94,852 | 52,976 | 32,059 | 19,511 | 7,856 | 3,358 |
Amortisation | 0 | 0 | 0 | 94 | 125 | 125 | 125 | 0 |
Tax | 0 | 693 | ||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 1,263,576 | 130,426 | 244,376 | 45,892 | 136,573 | 38,078 | 31,651 | 21,909 |
Creditors | -185,984 | 35,660 | 94,711 | 9,814 | 28,326 | 3,398 | -145 | 14,220 |
Accruals and Deferred Income | -199,652 | 122,227 | 26,729 | 1,938 | 12,190 | -3,225 | 37,130 | 2,663 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -261,759 | 1,301,369 | ||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -20,000 | 0 | -20,000 | -7,861 | 0 | 33 | 47,828 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||
interest | -91 | 0 | ||||||
cash flow from financing | 110,224 | -20,001 | ||||||
cash and cash equivalents | ||||||||
cash | 1,400,109 | 71,144 | 378,550 | 166,715 | 127,514 | -63,516 | 167,253 | 110,070 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 1,400,109 | 71,144 | 378,550 | 166,715 | 127,514 | -63,516 | 167,253 | 110,070 |
peak proteins ltd. Credit Report and Business Information
Peak Proteins Ltd. Competitor Analysis
Perform a competitor analysis for peak proteins ltd. by selecting its closest rivals, whether from the ACTIVITIES OF EXTRATERRITORIAL ORGANISATIONS AND BODIES sector, other small companies, companies in NG1 area or any other competitors across 12 key performance metrics.
peak proteins ltd. Ownership
PEAK PROTEINS LTD. group structure
Peak Proteins Ltd. has no subsidiary companies.
Ultimate parent company
2 parents
PEAK PROTEINS LTD.
09265797
peak proteins ltd. directors
Peak Proteins Ltd. currently has 4 directors. The longest serving directors include Mr Simon Hirst (Apr 2022) and Jonathan Williams (Apr 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Simon Hirst | United Kingdom | 60 years | Apr 2022 | - | Director |
Jonathan Williams | United Kingdom | 61 years | Apr 2022 | - | Director |
Mr Jonathan Williams | United Kingdom | 61 years | Apr 2022 | - | Director |
Mrs Louisa Jordison | United Kingdom | 46 years | Apr 2022 | - | Director |
P&L
March 2023turnover
3.9m
+9%
operating profit
1.2m
+3%
gross margin
85.1%
+0.51%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
4.3m
+0.42%
total assets
4.3m
+0.26%
cash
2.4m
+1.46%
net assets
Total assets minus all liabilities
peak proteins ltd. company details
company number
09265797
Type
Private limited with Share Capital
industry
99999 - Dormant Company
72110 - Research and experimental development on biotechnology
incorporation date
October 2014
age
10
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
BDO LLP
address
the discovery building biocity, pennyfoot street, nottingham, nottinghamshire, NG1 1GR
Bank
-
Legal Advisor
-
peak proteins ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to peak proteins ltd..
peak proteins ltd. Companies House Filings - See Documents
date | description | view/download |
---|